General Information of the Compound
Compound ID
CP0485735
Compound Name
4-hexyl-N-quinolin-3-ylbenzamide
    Show/Hide
Synonyms
4-hexyl-N-(quinolin-3-yl)benzamide
CHEMBL258623
SCHEMBL846650
    Show/Hide
Structure
Formula
C22H24N2O
Molecular Weight
332.447
Canonical SMILES
CCCCCCc1ccc(cc1)C(=O)Nc1cnc2ccccc2c1
    Show/Hide
InChI
InChI=1S/C22H24N2O/c1-2-3-4-5-8-17-11-13-18(14-12-17)22(25)24-20-15-19-9-6-7-10-21(19)23-16-20/h6-7,9-16H,2-5,8H2,1H3,(H,24,25)
    Show/Hide
InChIKey
RTKCLHOLWGNTOT-UHFFFAOYSA-N
Physicochemical Property
logP
5.6099
Rotatable Bonds
7
Heavy Atom Count
25
Polar Areas
41.99
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44450347
ChEMBL ID
CHEMBL258623
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
2
Ki = 190 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 4-hexyl-N-(quinolin-3-yl)benzamide )
Drug Name 4-hexyl-N-(quinolin-3-yl)benzamide
Target(s)
Transient receptor potential cation channel V1 (TRPV1)
Inhibitor